HFA Premium Access

Blood pressure response and safety outcomes with vericiguat in the VICTORIA trial

Congress Session

About the speaker

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)
102 presentations
16 followers

9 more presentations in this session

Long-term outcomes in heart failure with preserved ejection fraction: predictors of cardiovascular and non-cardiovascular mortality

Speaker: Ms A. Shahim (Stockholm, SE)

Thumbnail

The impact of multimorbidity on mortality in heart failure with reduced ejection fraction (HFrEF): Which comorbidities matter most?

Speaker: Doctor P. Dewan (Glasgow, GB)

Thumbnail

Acute changes in estimated glomerular filtration rate following initiation of dapagliflozin in patients with heart failure and reduced ejection fraction: insights from DAPA-HF

Speaker: Doctor K. Docherty (Glasgow, GB)

Thumbnail

Clinical outcome predictions for the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trial

Speaker: Doctor R. Mentz (Durham, US)

Thumbnail

Features of changes in the level of profibrotic factors and their relationship with parameters of left ventricular mechanics in epicardial obesity

Speaker: Doctor O. Gritsenko (Barnaul, RU)

Thumbnail

Access the full session

Chronic Heart Failure - Pathophysiology and Mechanisms 2

Speakers: Professor C. Lam, Ms A. Shahim, Doctor P. Dewan, Doctor K. Docherty, Doctor R. Mentz...
Thumbnail

About the event

Image

Heart Failure 2021 Online Congress

29 June - 1 July 2021

Sessions Presentations

Related content

ESC Premium Access

Choosing wisely: ablation or medication for rhythm control in atrial fibrillation – discussion.

27 August 2021

ESC Premium Access

The role of modifiable risk factors for the maintenance of sinus rhythm in the atrial fibrillation patient.

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

This platform is supported by

logo Novo Nordisk